xCT Positive Control for STJ506326 peptide (STJ506328)
SPECIFICATIONS
ImmunogenPartially purified human SLC7A11 protein.
General Information
| Short Description | xCT Positive Control for STJ506326 is synthetically produced from the 275-325 sequence and is suitable for use in western blot applications. |
| Applications | WB |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Provided as 100 uL ready-to-use, in SDS-PAGE sample buffer (Laemelli's buffer) containing Tris, pH 6.8, 1 % SDS, Glycerol and Bromophenolblue blue as tracking dye. The sample is reduced by adding 2% beta mercaptoethanol. The protein concentration is |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Gene Symbol | SLC7A11 |
| Gene ID | 23657 |
| Uniprot ID | XCT_HUMAN |
| Immunogen | Partially purified human SLC7A11 protein. |
| Immunogen Region | 275-325 |
| Specificity | This is positive control is recommended for use in combination with xCT antibody STJ506326. |
Additional Info
| Tissue Specificity | Expressed in term placenta and primary term cytotrophoblast. Expressed mainly in the brain, but also in pancreas. |
| Post Translational Modifications | Ubiquitinated by TRIM26.leading to proteasomal degradation. |
| Function | Heterodimer with SLC3A2, that functions as an antiporter by mediating the exchange of extracellular anionic L-cystine and intracellular L-glutamate across the cellular plasma membrane. Provides L-cystine for the maintenance of the redox balance between extracellular L-cystine and L-cysteine and for the maintenance of the intracellular levels of glutathione that is essential for cells protection from oxidative stress. The transport is sodium-independent, electroneutral with a stoichiometry of 1:1, and is drove by the high intracellular concentration of L-glutamate and the intracellular reduction of L-cystine. In addition, mediates the import of L-kynurenine leading to anti-ferroptotic signaling propagation required to maintain L-cystine and glutathione homeostasis. Moreover, mediates N-acetyl-L-cysteine uptake into the placenta leading to subsequently down-regulation of pathways associated with oxidative stress, inflammation and apoptosis. In vitro can also transport L-aspartate. May participate in astrocyte and meningeal cell proliferation during development and can provide neuroprotection by promoting glutathione synthesis and delivery from non-neuronal cells such as astrocytes and meningeal cells to immature neurons. Controls the production of pheomelanin pigment directly. |
| Peptide Name | Cystine/Glutamate TransporterAmino Acid Transport System Xc-Calcium Channel Blocker Resistance Protein Ccbr1Solute Carrier Family 7 Member 11Xct |
| Database Links | Reactome: R-HSA-210991Reactome: R-HSA-352230Reactome: R-HSA-9818027 |
| Cellular Localisation | Cell MembraneMulti-Pass Membrane ProteinCell ProjectionMicrovillus MembraneLocalized To The Microvillous Membrane Of The Placental Syncytiotrophoblast |
| Alternative Peptide Names | Cystine/Glutamate Transporter proteinAmino Acid Transport System Xc- proteinCalcium Channel Blocker Resistance Protein Ccbr1 proteinSolute Carrier Family 7 Member 11 proteinXct proteinSLC7A11 protein |
Information sourced from Uniprot.org